期刊文献+

严重冠脉狭窄患者血清二甲基精氨酸水平与侧支循环形成的关系 被引量:2

暂未订购
导出
摘要 目的探讨严重冠脉狭窄患者侧支循环形成与否与血清二甲基精氨酸(ADMA)浓度的关系。方法经冠状动脉造影收集主要冠脉至少有一支狭窄程度在95%以上的123例冠心病患者,测定其血清ADMA浓度。采用Rentrop方法对冠状动脉侧支循环进行分级,0级为侧支循环未形成组(n=63),1~3级为侧支循环形成组(n=60)。结果侧支循环未形成组血清ADMA浓度(2.43±0.78)μmol/L显著高于侧支循环形成组(1.95±0.72)μmol/L(P〈0.01)。结论严重冠脉狭窄患者血清ADMA浓度与侧支循环形成有关。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2011年第13期2454-2455,共2页 Chinese Journal of Gerontology
  • 相关文献

参考文献7

  • 1Duan J, Murohara T, Ikeda H, et al. Hypercholesterolemia inhibits angio-genesis in response to hindlimb ischemia:nitric oxide-dependent mecha-nism[J]. Circulation ,2000 ; 102 (3) : Ⅲ370-6.
  • 2Jacobi J, Sydow K, yon Degenfeld G, et al. Overexpression of dimethyl-arginine dimethylaminohydrolase reduces tissue asymmetric dimethylargi-nine levels and enhances angiogenesis [J]. Am Heart Asso, 2005 ; 111(11):1431-8.
  • 3Kocaman SA, Sahinarslan A, Biberoglu G,et al. Asymmetric dimethylargi-nine and coronary collateral vessel development[J]. Coron Artery Dis,2008 ;19(7) :469-74.
  • 4Selcuk MT, Selcuk H, Temizhan A, et al. The effect of plasma asymmetricdimethylarginine (ADMA) level and L-arginine/ADMA ratio on the de-velopment of coronary collaterals [J]. Turk Kardiyol Dern Ars, 2008 ; 36(3) :150-5.
  • 5Schulze F, Lenzen H, Hanefeld C, et al. Asymmetric dimethylarginine isan independent risk factor for coronary heart disease: results from themulticenter Coronary Artery Risk Determination investigating the Influ-ence of ADMA Concentration (CARDIAC) study[J]. Am Heart J ,2006;152(3) :493 ,el-8.
  • 6Boger RH. The emerging role of asymmetric dimethylarginine as a novel Cardiovascular risk factor [J]. Cardiovasc Res, 2003 ;59 (4) : 824-33.
  • 7游咏,莫靓,桂庆军,李传昶,杨天伦.不同程度冠状动脉狭窄患者血清ADMA水平分析[J].山东医药,2010,50(24):94-96. 被引量:5

二级参考文献6

  • 1游咏,杨天伦,李传昶,蒲晓群,郑昭芬,陈美芳.冠状动脉严重狭窄患者侧支循环形成与血清非对称性二甲基精氨酸和细胞间粘附分子1水平的关系[J].中国动脉硬化杂志,2006,14(5):441-443. 被引量:4
  • 2Guthikonda S,Sinkey C,Barenz T,et al.Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers[J].Circulation,2003,107(3):416-421.
  • 3Cooke JP.Does ADMA cause endothelial dysfunction[J].Arterioscler Thromb Vasc Biol,2000,20(9):2032-2037.
  • 4Boger RH.The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor[J].Cardiovasc Res,2003,59(4):824-833.
  • 5Schulze F,Lenzen H,Hanefeld C,et al.Asymmetric dimethylarginine is an independent risk factor for coronary heart disease:results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study[J].Am Heart J,2006,152(3):493.e1-e8.
  • 6Stuhlinger MC,Abbasi F,Chu JW,et al.Relationship between insulin resistance and an endogenous nitric oxides synthase inhibitor[J].JAMA,2002,287(11):1420-1426.

共引文献4

同被引文献10

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部